Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants


Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 - More infoView PDF  Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19.…[...]

What are the side effects of the new COVID vaccine? Here’s what to know before getting the shot


Dalia Faheid, October 9, 2023 Ft Worth Telegram In September, updated COVID-19 vaccines targeting a newer strain of the omicron variant were approved for use in the United States and are now…[...]